Cargando…
Peanut oral immunotherapy: current trends in clinical trials
Immunotherapy for allergy has been practiced for over 100 years. Low-dose repeated exposure to specific allergen extracts over several months to years can successfully induce clinical tolerance in patients with allergy to insect venoms, pollen, house dust mite, and domestic animals. Different regime...
Autores principales: | Reinwald, Simone, Rolland, Jennifer M, O’Hehir, Robyn E, van Zelm, Menno C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327116/ https://www.ncbi.nlm.nih.gov/pubmed/35919493 http://dx.doi.org/10.1093/immadv/ltac004 |
Ejemplares similares
-
A summary of current NKG2D-based CAR clinical trials
por: Curio, Sophie, et al.
Publicado: (2021) -
The MARVEL trial: a phase 2b randomised placebo-controlled trial of oral MitoQ in moderate ulcerative colitis
por: Gwyer Findlay, Emily, et al.
Publicado: (2020) -
A glutamine ‘tug-of-war’: targets to manipulate glutamine metabolism for cancer immunotherapy
por: Pallett, Laura J, et al.
Publicado: (2021) -
An overview of CAR T-cell clinical trial activity to 2021
por: Adami, Antonella, et al.
Publicado: (2021) -
Beyond Ipilimumab: a review of immunotherapeutic approaches in clinical trials in melanoma
por: Middleton, Gary
Publicado: (2020)